RachelERauMD

PubMed

• Recombinant Erwinia asparaginase (JZP458) in ALL/LBL: complete follow-up of the Children's Oncology Group AALL1931 study.
  Luke Maese, Mignon L Loh, Mi Rim Choi, Shirali Agarwal, Etsuko Aoki
  Blood Advances. 2025-01-14
• 1 citations
  Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children.
  Sumit Gupta, Rachel E Rau, John A Kairalla, Karen R Rabin, Cindy Wang
  The New England Journal of Medicine. 2024-12-07
• Brain abscesses, neutropenia, and B-ALL: Multiple testing modalities required to confirm PDCD10 and ETV6 dual diagnoses.
  Runjun D Kumar, Liesbeth Vossaert, Weimin Bi, Nichole Owen, Rachel E Rau
  Cancer Genetics. 2024-11-01

Abstracts/Posters

• Targeting Activated Signaling Pathways for the Treatment of IKZF1-Deleted B Lymphoblastic Leukemia
  Rachel E. Rau, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Open-Label, Multicenter, Phase 2/3 Study of Recombinant Crisantaspase Produced in Pseudomonas Fluorescens (RC-P) in Patients with Acute Lymphoblastic Leukemia (ALL) or...
  Rachel E. Rau, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Novel Short Latency, High Penetrance Model of KRAS Mutation-Driven T-Cell Acute Lymphoblastic Leukemia
  Rachel E. Rau, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Phase I Study of the Selinexor in Relapsed/Refractory Childhood Acute Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Mosaic DNMT3A Germline Mutation As a Model for Mutant DNMT3A Competitive Advantage in the Blood Lineage 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018